Assessment of radioiodine clearance in patients with differentiated thyroid cancer

被引：0
|
作者：
Tabei, F. [1 ]
Asli, I. Neshandar [2 ]
Azizmohammadi, Z. [2 ]
Javadi, H. [3 ]
Assadi, M. [4 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Dept Med Phys & Engn, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Taleghani Hosp, Dept Nucl Med, Tehran, Iran
[3] Golestan Univ Med Sci GUOMS, Golestan Res Ctr Gastroenterol & Hepatol GRCGH, Gorgan, Iran
[4] Bushehr Univ Med Sci, Persian Gulf Nucl Med Res Ctr, Bushehr, Iran
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0156
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [21] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Kinuya, Seigo
    Yokoyama, Kunihiko
    Michigisuh, Takatoshi
    Tonami, Norihisa
    ANNALS OF NUCLEAR MEDICINE, 2006, 20 (07) : 499 - 502
  • [22] Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients
    Verburg, FA
    de Keizer, B
    Lips, CJM
    Zelissen, PMJ
    de Klerk, JMH
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (01) : 33 - 37
  • [23] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Seigo Kinuya
    Kunihiko Yokoyama
    Takatoshi Michigishi
    Norihisa Tonami
    Annals of Nuclear Medicine, 2006, 20
  • [24] The efficacy of low dose radioiodine therapy in differentiated thyroid cancer patients
    Yoon, S.
    Choi, B.
    Hong, S.
    Joh, C.
    Yoon, J.
    Lee, K.
    So, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S374 - S374
  • [25] INFLUENCE OF HYDROCHLOROTHIAZIDE ON URINARY EXCRETION OF RADIOIODINE IN PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Ignjatovic, V. D.
    Vukomanovic, V.
    Jeremic, M.
    Ignjatovic, V. S.
    Matovic, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2015, 11 (03) : 396 - 400
  • [26] Impact of age on survival in radioiodine refractory differentiated thyroid cancer patients
    Saie, C.
    Wassermann, J.
    Mathy, E.
    Chereau, N.
    Leenhardt, L.
    du Montcel, S. Tezenas
    Buffet, C.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (05) : 667 - 676
  • [27] THYROID SUPPRESSION AND RADIOIODINE TREATMENT FOR DIFFERENTIATED THYROID-CANCER
    ROSLER, H
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1987, 113 (07) : 778 - 778
  • [28] Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira, Margarida
    Vaz, Sofia Carrilho
    Esteves, Susana
    Ferreira, Teresa C.
    Limbert, Edward
    Salgado, Lucilia
    Leite, Valeriano
    THYROID, 2017, 27 (08) : 1068 - 1076
  • [29] Use of Radioiodine after Thyroid Lobectomy in Patients with Differentiated Thyroid Cancer: Does It Change Outcomes?
    Kiernan, Colleen M.
    Parikh, Alexander A.
    Parks, Lee L.
    Solorzano, Carmen C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 220 (04) : 617 - 625
  • [30] The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer
    Demir, Ahmet Numan
    Kara, Zehra
    Sulu, Cem
    Uysal, Serhat
    Zulfaliyeva, Guldana
    Atar, Oznur Aydin
    Valikhanova, Nahida
    Ozturk, Tulin
    Ozkaya, Hande Mefkure
    Damci, Taner
    Gonen, Mustafa Sait
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2023, 22 (04): : 595 - 602
12345